Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-200
Closed -$4K 632
2017
Q1
$4K Hold
200
﹤0.01% 528
2016
Q4
$4K Hold
200
﹤0.01% 539
2016
Q3
$4K Hold
200
﹤0.01% 513
2016
Q2
$4K Hold
200
﹤0.01% 491
2016
Q1
$4K Hold
200
﹤0.01% 438
2015
Q4
$3K Hold
200
﹤0.01% 441
2015
Q3
$3K Hold
200
﹤0.01% 363
2015
Q2
$3K Hold
200
﹤0.01% 374
2015
Q1
$3K Hold
200
﹤0.01% 382
2014
Q4
$4K Hold
200
﹤0.01% 364
2014
Q3
$5K Hold
200
﹤0.01% 325
2014
Q2
$5K Hold
200
﹤0.01% 325
2014
Q1
$5K Hold
200
﹤0.01% 325
2013
Q4
$5K Buy
+200
New +$5.03K ﹤0.01% 310

Other funds holding ADTN

Oakworth Capital's ADTN Position: Q2 2017 in Review

Oakworth Capital sold out of Adtran (ADTN) in Q2 2017, closing a stake of 200 shares — an estimated $4K sold.

Oakworth Capital first reported a position in ADTN in Q4 2013 and held it in 14 quarters. The position peaked at $5K in Q3 2014. 155 funds tracked by Wall St. Rank hold ADTN as of Q2 2017.

  • Oakworth Capital reported no remaining Adtran position as of Q2 2017 after selling out during the quarter.
  • Oakworth Capital sold 200 Adtran shares in Q2 2017, an estimated $4K.
  • Oakworth Capital first reported a position in Adtran in Q4 2013 and held it in 14 quarters.
  • Oakworth Capital's Adtran position peaked at $5K in Q3 2014.
  • 155 funds tracked by Wall St. Rank held Adtran as of Q2 2017.

Based on Oakworth Capital's 13F filing for Q2 2017, filed 31 Jul 2017.